Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: Results of a randomized controlled trial-Reference-Cited by-同舟云学术

Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: Results of a randomized controlled trial

Published:2006-12 Issue:6 Volume:55 Page:1003-1013
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Parish Lawrence Charles,Jorizzo Joseph Lucius,Breton John Jeffrey,Hirman Joseph William,Scangarella Nicole Elizabeth,Shawar Ribhi Mohammad,White Scott Matthew

Publisher

Elsevier BV

Subject

Dermatology

Reference39 articles.

1. Secondary bacterial infections complicating skin lesions;Brook;J Med Microbiol,2002

2. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin;Cho;J Allergy Clin Immunol,2001

3. Endogenous antimicrobial peptides and skin infections in atopic dermatitis;Ong;N Engl J Med,2002

4. Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections;Henderson;Br J Dermatol,1988

5. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens;Leung;J Clin Invest,1993

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles of Topical Therapy;Rook's Textbook of Dermatology;2024-02-20

2. Superficial Bacterial Skin Infections and Cellulitis;Principles and Practice of Pediatric Infectious Diseases;2023

3. Derivation of a Precise and Consistent Timeline for Antibiotic Development;Antibiotics;2022-09-12

4. Retapamulin: Current Status and Future Perspectives;Archives of Clinical Infectious Diseases;2021-12-04

5. A comparative review of current topical antibiotics for impetigo;Expert Opinion on Drug Safety;2021-04-13